TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback

Get the Brief in your inbox

A daily, SEC-grounded read on the market — movers, earnings, and our boldest calls. Free.

TTENK/calls

SEC-grounded equity research — opinionated calls reasoned over real filings.

Research

  • The Brief
  • Markets
  • All Stocks
  • Screener
  • Discover
  • Research
  • The Flip Side
  • Track record

Tools

  • Compare
  • Congress trades
  • Events
  • Filing search
  • Options calculator
  • Leaderboards
  • Insider trades
  • Groups
  • Trending
  • News

More

  • Pricing
  • Feedback
  • Newsletter
  • Developers / API
  • Account
DisclosuresTermsPrivacy

Research & education only — not financial advice.TENK is not a registered investment adviser; calls are impersonal, generated from SEC filings and a delayed/third-party price feed, and may be wrong or out of date. The operator and an affiliated trading operation may hold or trade the securities TENK rates — see Disclosures. Do your own research.

EDGAR® is a registered trademark of the U.S. Securities and Exchange Commission. TENK/calls is an independent service and is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.

TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback

Pulling SEC filings + quote and writing the call…

TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback
← New search
Home›Stocks›CELH
CELH logo

CELH

Celsius Holdings, Inc.

Next earnings Aug 5, 2026 (before open) · consensus $0.45 EPS, $912M rev

Last earnings +4.5% on 2026-05-07

Hold
$33.16
▲ +11.31%
$33.16▼ -27.74%
over 1Y
L $27.75H $64.86
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today+11.3%
1W+17.5%
1M+8.6%
3M-2.7%
YTD-30.6%
1Y-27.7%
OverviewFinancialsValuationQualityTimelineFilings
Rating
Hold
Quality
C
Valuation
Overvalued
Filings
Watch
Hold
Conviction
Horizon
Medium (3–12mo)
Street · 29 analysts
Buy

Energy-drink rollup with explosive M&A-driven revenue but falling EPS at 123x earnings; integration must prove out before the multiple is earned.

Revenue (FY2025) $2.52B · FY2025

The read

Middling fundamentals and a rich price (~71% above fair value) leave little margin of safety — a wait-and-see.

Celsius transformed itself in 2025 from a single-brand functional energy company into a three-brand portfolio, acquiring Alani Nu (April 2025) and Rockstar (August 2025) and deepening its Pepsi distribution partnership. The headline growth is dramatic: revenue jumped 85.5% to $2.52B and gross profit rose 86.3% to $1.27B at a healthy 50.4% gross margin. But the acquisitions came at a cost to the per-share story — net income actually fell 25.6% to $108M and diluted EPS dropped 44.4% to $0.25, as operating income slipped 9.4% to $141M and the share count grew 9.3% to fund the deals. The result is an operating margin of just 5.6% and net margin of 4.3% on a vastly larger but lower-quality (acquired) revenue base.

The balance sheet was reshaped accordingly. Total assets nearly tripled to $5.12B (goodwill/intangibles from the deals), total liabilities surged 301.5% to $2.18B including $670M of new long-term debt, and cash fell 55.2% to $399M. Leverage moved to 1.84x liabilities/equity from a previously cash-rich position. Encouragingly, operating cash flow still grew 36.7% to $359M, so the underlying brands generate cash even as reported earnings absorbed integration and financing costs.

Is CELH a buy? The one-page verdict, explained →

The options angle

model · matches our verdict
Covered call~60d expiry
  • Long 100 shares @ ~33.16
  • Short call 35 @ ~2.65 est
debit $3,051max +$449max −$3,050BE 30.51

HOLD means own it, don't chase it — harvesting premium against the position matches the verdict.

Open in the calculator →

Educational template, not a trade recommendation. Strikes and premiums are Black-Scholes model estimates from the last close and 30-day realized volatility — real chains, spreads and IV will differ. Options involve substantial risk.

Financials · annual, by fiscal year

Line itemFY21FY22FY23FY24FY25
Revenue—$654M$1.32B$1.36B$2.52B
Gross profit$128M$271M$633M$680M$1.27B
Operating income-$4.09M-$158M$266M$156M$141M
Net income$3.94M-$187M$227M$145M$108M
Diluted EPS$0.02-$0.88$0.77$0.45$0.25
Net margin—-28.7%17.2%10.7%4.3%

Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.

Key statistics

Valuation

Enterprise value$8.76B
EV / EBITDA51.3
EV / Sales3.5
EV / FCF27.1
P / FCF26.2
PEG (trailing)—
Earnings yield1.3%
FCF yield3.8%

Quality & risk

ROIC (est.)6.0%
Free cash flow$323M
Total debt$677M
Net cash-$278M
Altman Z-Score3.14 safe
Piotroski F-Score4/9

Capital returns

Buyback yield0.1%
Dividend yield (est.)—
Shareholder yield0.1%
Shares Δ YoY+9.3%

Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.

Disclosure timeline

SEC · 8-Ks + reports
Some governance/structural items recently, but no outright red flags.
  1. 8-K Reg FD disclosure2026-06-01
  2. 8-K Shareholder vote2026-05-28
  3. 8-K Earnings results2026-05-07
  4. 10-Q Quarterly report2026-05-07
  5. DEF 14A Proxy statement2026-04-14
  6. 10-K Annual report2026-03-02
  7. 8-K Earnings results2026-02-26
  8. 8-K Officer / director change2026-02-10
  9. 8-K/A Amended 8-K2025-11-12

Recent filings

all on EDGAR ↗
8-KPeriod ending 2026-06-012026-06-01open ↗4Period ending 2026-05-302026-06-01open ↗3Period ending 2026-05-282026-06-01open ↗8-KPeriod ending 2026-05-282026-05-28open ↗4Period ending 2026-05-212026-05-26open ↗4Period ending 2026-05-222026-05-26open ↗4Period ending 2026-05-222026-05-26open ↗4Period ending 2026-05-172026-05-19open ↗SCHEDULE 13G/AFiling2026-05-18open ↗10-QPeriod ending 2026-03-312026-05-07open ↗8-KPeriod ending 2026-05-072026-05-07open ↗4Period ending 2026-05-052026-05-06open ↗

Quality score

C
ValueGrowthProfitHealthMom.
ValueD
GrowthC
ProfitabilityC+
Financial healthB
MomentumD
  • ✓Revenue growing year-over-year
  • ✓Profitable (positive net income)
  • ✗Net margin above 10%
  • ✗Return on equity above 15%
  • ✓Liabilities below 2× equity
  • ✗P/E below 25

Fair value est.

$9.50

Overvalued -71% vs price

cheapfair valueexpensive

Modified Graham: EPS $0.25 × (8.5 + 1.5 × 22.0% growth) × 0.95 quality = 38.0× multiple. An estimate, not a price target.

27.7552-week64.86
Revenue
$2.52B
+85.5% YoY
Net margin
4.3%
ROE
9.1%
P/E
132.6

SEC fundamentals · FY 2025

'21'22'23'24'25

■ revenue · ■ net income, by fiscal year

Revenue$2.52B+85.5%
Net income$108M-25.6%
Gross profit$1.27B+86.3%
Operating income$141M-9.4%
Diluted EPS$0.25-44.4%
Cash & equivalents$399M-55.2%
Total assets$5.12B+189.8%
Total liabilities$2.18B+301.5%
Stockholders' equity$1.18B+195.4%
Gross: 50.4%Op.: 5.6%L/E: 1.84x

Frequently asked

Is Celsius Holdings, Inc. (CELH) a buy?
CELH currently carries a Hold rating with 2/5 conviction, derived from its latest SEC filings. Energy-drink rollup with explosive M&A-driven revenue but falling EPS at 123x earnings; integration must prove out before the multiple is earned.
What is CELH's fair value?
A Modified-Graham model based on CELH's SEC fundamentals estimates a fair value of about $9.50. It is an estimate from reported earnings, not a price target.
Is CELH overvalued or undervalued?
Against a Modified-Graham fair-value estimate, CELH currently appears overvalued relative to its SEC-grounded earnings power.
What is Celsius Holdings, Inc.'s quality score?
CELH scores 55.94426429631511/100 (grade C) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.

Sources: SEC EDGAR (CIK 0001341766, latest 10-Q filed 2026-05-07) · EODHD · Proprietary analysis · as of 6/21/2026, 8:50:02 PM.

›About this recommendation — produced by TENK/calls (tenkcalls.com), Luxembourg · not investment advice

AI-generated analysis, produced by our proprietary engine from SEC filing data.

Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jun 21, 2026, 4:50 PM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.

Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.

Insider activity

Form 4 · SEC

Last 90 days: 3 open-market buys · 0 sales

2026-05-30
Hanson Eric
President & COO
Tax6.15K @ $33.27$204K
2026-05-22
Kravitz Hal
Director
Buy8.40K @ $29.73$250K
2026-05-22
Fieldly John
Chief Executive Officer
Buy8.47K @ $29.36$249K
2026-05-21
Hanson Eric
President & COO
Buy7.50K @ $29.04$218K
2026-05-17
Fieldly John
Chief Executive Officer
Tax1.06K @ $30.16$31.9K
2026-05-05
Storey Paul H.
Chief Supply Chain Officer
Tax2.02K @ $33.52$67.9K
2026-04-18
Langhans Jarrod
Chief Financial Officer
Tax4.39K @ $35.25$155K
2026-03-02
Russell Joyce
Director
Sell2.88K @ $51.31$148K
2026-02-27
Russell Joyce
Director
Award2.61K

Earnings history

beat/miss · move
2026-05-07Beat +35.5% est▲ +4.45%8-K ↗
2026-02-26Beat +23.6% est▲ +6.94%8-K ↗
2025-11-06Beat +49.2% est▼ -24.80%8-K ↗
2025-08-07Beat +93.3% est▲ +17.27%8-K ↗
2025-05-06—▲ +4.81%8-K ↗
2025-02-20—▼ -2.15%8-K ↗

Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.

Congressional trades

all activity →

Disclosed under the STOCK Act

2025-02-13Rob BresnahanSell$1.00K–$15.0KPTR ↗
2024-10-03Josh GottheimerSell$1.00K–$15.0KPTR ↗
2024-01-07Josh GottheimerBuy$1.00K–$15.0KPTR ↗
2023-12-08Josh GottheimerBuy$1.00K–$15.0KPTR ↗
2023-12-08Josh GottheimerBuy$1.00K–$15.0KPTR ↗
2023-02-24Daniel GoldmanSell$1.00K–$15.0KPTR ↗

Self-reported periodic transaction reports (STOCK Act). Amounts are disclosed ranges; a trade may be a spouse's. Disclosures lag the trade by up to ~45 days. Source: House Clerk + Senate eFD.

Vs tracked universe

compare →

1194 tracked peers · median

TENK Score56 vs 67
Revenue growth85.5% vs 7.5%
Net margin4.3% vs 10.0%
Return on equity9.1% vs 12.0%
P/E132.6 vs 26.2

News sentiment

EODHD · 41d
Bearish
-0.07
vs typical · 107 articles

Recent news tone vs the market's typical (which skews positive). A soft signal, not a recommendation.